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Abstract 
Transplanted and hemodialysis patients are frequently affected by parasitic diseases such as cryptosporidiosis. Crypto-
sporidium is a parasite causing self-limited diarrhea and enteritis in healthy individuals. The presence of Cryptosporidium 
infection was studied in three groups including 87 renal transplant patients, 103 hemodialysis patients, and 60 healthy indi-
viduals as the control group. Two stool specimens were obtained from each case. The specimens were concentrated by the 
formalin-ether method and two smears were prepared from each. The smears were stained by modified acid-fast method and 
were observed under a light microscope. Ten (11.5%) renal transplant and 4 (3.88%) hemodialysis patients were positive for 
Cryptosporidium infection. No positive results were obtained in the control group. The results showed a statistically signifi-
cant difference between renal transplant and control groups (P= 0.02), but the difference between hemodialysis and control 
groups was not significant (P= 0.2). The results also showed that the rate of Cryptosporidium infection in renal transplant 
patients was much higher than hemodialysis patients. The susceptibility of renal transplant patients to Cryptosporidium in-
fection is much more than other studied groups and this could be due to immunosuppressive therapy in these patients. 
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Introduction 
Cryptosporidium is one of the intestinal proto-
zoa belonging to the subclass of Coccidia. This 
important pathogenic parasite was described for 
the first time by Clarke in 1895. He observed 
oocysts of this parasite in the gastric epithelial 
cells of the mouse (1). Almost 12 years later, in 
1907, Tyzzer isolated this parasite from the 
gastric mucosa of mice with no clinical signs. 
In 1976, the first human case was reported (2-4). 
The epidemiology of cryptosporidiosis is very 
similar to giardiasis. Clinically, Cryptosporid-
ium infection can lead to a variety of signs and 
symptoms. It can cause severe and prolonged 
diarrhea in patients with immunodeficiency and 
AIDS, and in infants (4, 5). In the past, Crypto-
sporidium was considered as a gastrointestinal 
parasite in young animals (e.g. cattle). But, to-
day, as its pathogenic role in human has been 
recognized, it is considered as one of the most 
common pathogens in both humans and animals 
(6). 
Cryptosporidium infection can persist for a long 
time and can lead to serious complications in 
patients with AIDS, renal transplant or cancer 
patients (7-9). But, in patients with an intact 
immune system, this organism leads to a self-
limited infection. There is an indirect relation 
between the duration of infection and the CD4+ 
cell count (1, 2, 10). 
Urmia is located in north-west of Iran and is the 
center of West Azerbaijan Province. As Urmia 
is a cattle-raising area and there are active kid-
ney transplantation departments in this city, this 
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study has been performed to determine the 
prevalence of cryptosporidiosis in this city. 
 
Materials and Methods 
All patients who underwent renal transplanta-
tion were entered into this study from 1997 
through 1999. Of 170 patients, 15 patients died, 
14 were under dialysis because of rejection of 
the transplanted kidney, and 16 did not refer to 
the renal transplantation center. Thirty eight pa-
tients refused to participate in the study. The 
remaining 87 were allocated to the experimen-
tal group. Thirty non-immunosuppressed cases 
were selected from different wards as the con-
trol group. Totally, 178 samples were collected; 
of which 150 samples belonged to 75 patients 
(two samples each) and the rest belonged to 28 
patients who were taken only one sample each. 
In the year 2000, 128 patients were hospitalized 
for hemodialysis in Taleghani teaching hospital. 
Of which, 103 cases participated in this study. 
Stool samples of all patients were sent for ex-
amination. In addition, 30 cases (20 from urban 
and 10 from rural areas) were selected as con-
trols. A questionnaire was designed for collec-
tion of information such as age, sex, date of 
transplantation, duration of hemodialysis, con-
tact with animals and diarrhea. Each case re-
ceived two stool specimen containers and was 
asked to return the samples in one week. 
The samples were concentrated by formalin-
ether method. A drop was taken from each de-
posit by Pasture pipette and was smeared on a 
glass slide. The slides were stained by modified 
acid-fast method. In this method, oocysts of 
Cryptosporidium were visualized as red spots 
on blue background. All the smears were ex-
amined by light microscope with ×100 objec-
tive. χ2 test was used for statistical comparison 
of two proportions. 
 
Results 
Of 87 renal transplant patients, 57 (32 females 
and 25 males) were from urban areas. Exami-
nation of the samples revealed that 10 (11.5%) 
patients in the renal transplant group were 
positive for Cryptosporidium infection. None of 
the samples in the control group were positive 
for this infection and the difference was statisti-
cally significant (P= 0.02).  
Of 103 hemodialysis patients with an average 
age of 50 yr and an average duration of hemo-
dialysis of 3 yr, 55 were male. Among these 
patients, 4(3.88%) cases (3 males and 1 female) 
of contamination were detected. No contami-
nated case could be detected in the control group. 
The relationship between control and experi-
mental groups was not significant. But, there 
was a positive relationship between duration of 
hemodialysis and contamination with parasite 
(P= 0.001).  
 
Discussion 
Cryptosporidium has been known as an impor-
tant cause of watery or mucoid diarrhea in im-
muno-competent persons that heals spontane-
ously in several days or weeks. Because of low 
sanitary levels, in developing countries, infec-
tion with this parasite occurs mostly in the first 
years of the life, but in developed countries the 
infection can be linked to day care or schooling 
(6). While self-limiting in immunocompetents, 
a chronic, long lasting diarrhea (sometimes 
deadly) and even extra-intestinal illnesses can 
be seen in immuno-compromised patients espe-
cially those with lower counts of CD4+ cells.  
As renal transplantation recipients receive im-
munosuppressive drugs for all their life, they 
not only need lower dose of organisms to be 
infected, but also may produce more sever 
symptoms. This study showed higher preva-
lence of cryptosporidiosis among these patients 
compared to the control group and was in con-
cordance with previous studies (11, 12). Ok et 
al. could find such a significant relation be-
tween Cryptosporidium infection and renal 
transplantation. In their study 18.8% of trans-
planted patients and 7.1% of control group were 
infected (11). Although Chieffi et al. were un-
able to find statistically significant relation, but 
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the infection rate was yet higher in renal trans-
plant recipients (34.8%) than controls (17.4%) 
(12). 
Patients undergoing hemodialysis were also 
assayed for Cryptosporidium infection and their 
infection rate was higher than controls but no 
significant relation was achieved. This was in 
agreement with Chieffi et al. (25% and 17.4%, 
resp.) (12), and in contrast with Seirafian et al. 
(11.5% and 3.9%, in that order) (13) and Turk-
capar et al. (20.7% and 0%, respectively) (14).      
The infectious dose of Cryptosporidium is rela-
tively low and in some isolates, infection may 
be acquired by ingesting only one oocyst. The 
oocysts are fully infective when shed and this 
way of infection takes place easily. They are 
also very resistant to environmental conditions 
and in moist places can remain infective for six 
months. Their small size and resistance to chlo-
rine facilitate water transmission. Finally some 
of genotypes have important animal reservoirs 
like cattle (6). So Cryptosporidium has a poten-
tially high infectivity, and transmission occurs 
with no trouble. 
Above mentioned studies show the higher 
prevalence of Cryptosporidium infection among 
renal transplantation recipients than normal popu-
lation. As treatment is not always feasible in 
these patients and also they receive immunosup-
pressive drugs, preventing measures like drink-
ing boiled water, avoiding contact with infected 
people or young pets and avoiding swallowing 
water while swimming need to be employed (15). 
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